{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:15:47Z","timestamp":1781763347834,"version":"3.54.5"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"DOI":"10.1038\/s41387-024-00317-y","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T18:14:48Z","timestamp":1731608088000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anti-obesity effect of irreversible MAO-B inhibitors in patients with Parkinson\u2019s disease"],"prefix":"10.1038","volume":"14","author":[{"given":"Siyu","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"317_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1172\/JCI59660","volume":"122","author":"JP Thaler","year":"2012","unstructured":"Thaler JP, Yi CX, Schur EA, Guyenet SJ, Hwang BH, Dietrich MO, et al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest. 2012;122:153\u201362.","journal-title":"J Clin Invest"},{"key":"317_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2012.09.020","volume":"151","author":"D Kong","year":"2012","unstructured":"Kong D, Tong Q, Ye C, Koda S, Fuller PM, Krashes MJ, et al. GABAergic RIP-Cre neurons in the arcuate nucleus selectively regulate energy expenditure. Cell 2012;151:645\u201357.","journal-title":"Cell"},{"key":"317_CR3","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1038\/s42255-023-00923-7","volume":"5","author":"M Sa","year":"2023","unstructured":"Sa M, Yoo ES, Koh W, Park MG, Jang HJ, Yang YR, et al. Hypothalamic GABRA5-positive neurons control obesity via astrocytic GABA. Nat Metab. 2023;5:1838.","journal-title":"Nat Metab"},{"key":"317_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aav0316","volume":"5","author":"JH Park","year":"2019","unstructured":"Park JH, Ju YH, Choi JW, Song HJ, Jang BK, Woo J, et al. Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer\u2019s disease. Sci Adv. 2019;5:eaav0316.","journal-title":"Sci Adv"},{"key":"317_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107861","volume":"32","author":"MH Nam","year":"2020","unstructured":"Nam MH, Cho J, Kwon DH, Park JY, Woo J, Lee JM, et al. Excessive astrocytic GABA causes cortical hypometabolism and impedes functional recovery after subcortical stroke. Cell Rep. 2020;32:107861.","journal-title":"Cell Rep."},{"key":"317_CR6","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nm.3639","volume":"20","author":"S Jo","year":"2014","unstructured":"Jo S, Yarishkin O, Hwang YJ, Chun YE, Park M, Woo DH, et al. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer\u2019s disease. Nat Med. 2014;20:886\u201396.","journal-title":"Nat Med"},{"key":"317_CR7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.neuron.2008.10.013","volume":"60","author":"BA Barres","year":"2008","unstructured":"Barres BA. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron. 2008;60:430\u201340.","journal-title":"Neuron"},{"key":"317_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.tins.2009.08.002","volume":"32","author":"MV Sofroniew","year":"2009","unstructured":"Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009;32:638\u201347.","journal-title":"Trends Neurosci"},{"key":"317_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109901","volume":"117","author":"Z Tian","year":"2023","unstructured":"Tian Z, Wang X, Han T, Sun C. Selegiline ameliorated dyslipidemia and hepatic steatosis in high-fat diet mice. Int Immunopharmacol. 2023;117:109901.","journal-title":"Int Immunopharmacol"}],"container-title":["Nutrition & Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00317-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00317-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00317-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T19:02:54Z","timestamp":1731610974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00317-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["317"],"URL":"https:\/\/doi.org\/10.1038\/s41387-024-00317-y","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"11 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the guidelines laid down in the 1964 Declaration of Helsinki and its later amendments. All procedures involving human subjects were reviewed and approved by the Clinical Research Ethics Committee of PUMCH (approval number: I-24PJ1149). All the inpatients were informed that the data would be handled confidentially. Information about the study was given to all participants and participation was based on oral informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"92"}}